Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Not applicableStudy completedNCT03820024
What this trial is testing

MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback

Who this might be right for
Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center 39
Not applicableStudy completedNCT03027479
What this trial is testing

Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss

Who this might be right for
Weight LossOvarian CarcinomaEndometrial Carcinoma
University Hospital, Tours 70
Not applicableStudy completedNCT06550791
What this trial is testing

Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors

Who this might be right for
Neoplasm, Uterine
University of Virginia 23
Testing effectiveness (Phase 2)Study completedNCT04823065
What this trial is testing

4FMFES-PET Imaging of Endometrial and Ovarian Cancers

Who this might be right for
Endometrial CancerOvarian Cancer
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 53
Early research (Phase 1)Active Not RecruitingNCT02285192
What this trial is testing

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial Cancer
Memorial Sloan Kettering Cancer Center 42
Early research (Phase 1)Study completedNCT00575952
What this trial is testing

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+8 more
Gynecologic Oncology Group 27
Not applicableUnknownNCT05227898
What this trial is testing

Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With Cancer

Who this might be right for
Cancer
Blue Note Therapeutics 352
Not applicableNot Yet RecruitingNCT07339384
What this trial is testing

Signatera Assessment in Early-Stage Endometrial Cancer

Who this might be right for
Endometrial Cancer
Natera, Inc. 1,010
Not applicableStudy completedNCT00288821
What this trial is testing

Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology

Who this might be right for
Cervix NeoplasmsOvarian NeoplasmsEndometrial Neoplasms+2 more
UMC Utrecht 84
Large-scale testing (Phase 3)Looking for participantsNCT03651206
What this trial is testing

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Who this might be right for
Ovarian CarcinosarcomaEndometrial Carcinosarcoma
ARCAGY/ GINECO GROUP 138
Not applicableStudy completedNCT00732173
What this trial is testing

Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer

Who this might be right for
Endometrial Cancer
Case Comprehensive Cancer Center 74
Not applicableNot Yet RecruitingNCT06977594
What this trial is testing

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer
Seoul National University Hospital 1,000
Large-scale testing (Phase 3)Looking for participantsNCT04789694
What this trial is testing

Prehabilitation in Gynaecological Cancer Patients

Who this might be right for
Ovarian CancerOvarian Cancer Stage IIIOvarian Cancer Stage IV+2 more
Charles University, Czech Republic 64
Testing effectiveness (Phase 2)UnknownNCT03827837
What this trial is testing

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more
Jiangsu HengRui Medicine Co., Ltd. 265
Not applicableStudy completedNCT05977829
What this trial is testing

Endometrial Malignancy in Breast Cancer Patients With or Without AUB

Who this might be right for
Endometrial Neoplasms
University of Campania Luigi Vanvitelli 283
Not applicableLooking for participantsNCT07200466
What this trial is testing

Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

Who this might be right for
Endometrial Cancer
Radboud University Medical Center 735
Not applicableWithdrawnNCT07226102
What this trial is testing

Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Endometrial Carcinoma+10 more
City of Hope Medical Center
Not applicableLooking for participantsNCT05945407
What this trial is testing

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer

Who this might be right for
Endometrial NeoplasmsEndometrial Neoplasm MalignantEndometrial Neoplasm Malignant Stage I+2 more
Peking University People's Hospital 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07731607
What this trial is testing

Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer

Who this might be right for
MMRd Endometrial Cancer of Stage I~II
Wang Jianliu 48
Next Page